The announcement additionally noted that throughout 14 months of follow-up, UP421 maintained its pancreatic islet cell ...

Sana Biotechnology said a patient with type 1 diabetes transplanted with UP421, an allogeneic primary islet cell therapy, ...

patient cohort fully enrolled with an average time since transplant of approximately 8 months- 100% insulin independence achieved in 10 ...

Scientists in Shanghai have developed a potentially groundbreaking treatment for diabetes that targets the root cause of the ...

In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce ...

Chinese researchers have achieved a medical breakthrough by using endoderm stem cell-derived islet-like tissues (E-islet) to restore pancreatic islet function in patients with diabetes, potentially ...

Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression. 14-Month Follow-up Data Sho ...

A vascularized organoid model of hormone-secreting cells in the pancreas has been developed, with potential to improve diabetes research and cell-based therapies. “Our results highlight the importance ...

Tokyo, Japan – Researchers from Tokyo Metropolitan University have studied pancreatic islet cell loss in people with no previous pancreatic problems. They identified key trends in the types of cells ...

An investigational antibody could reduce the toxicity associated with immune suppression in islet cell transplantation for type 1 diabetes (T1D), according to new preliminary data. Six people with T1D ...

Lantidra therapy infuses healthy islet cells into patients' livers, with some achieving insulin independence. University ...

Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...